Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Krebs Biochemicals & Industries Ltd. Share Price
Day's Range
Day's Range
Low
₹64.74
High
₹71.50
Price Summary
| Previous Close | ₹68.93 |
|---|---|
| Day's Range | ₹64.74 - ₹71.50 |
| Open | ₹65.00 |
| 52 Week Range | ₹38.33 - ₹113.50 |
| Volume | 49,426 |
| Market Cap | ₹0.00 |
| Previous Close | ₹67.55 |
|---|---|
| Day's Range | ₹66.03 - ₹70.91 |
| Open | ₹66.03 |
| 52 Week Range | ₹38.52 - ₹113.90 |
| Volume | 3,171 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 34.07 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -7.85 |
| P/E Ratio | 0.00 |
| Book Value(₹) | -0.85 |
| PAT Margin (%) | -62.20 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -29.92 |
| Trade Value ( ₹ in Lacs) | 2.14 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -7.85 |
| P/E Ratio | 0.00 |
| Book Value(₹) | -0.85 |
| PAT Margin (%) | -62.20 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -29.92 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 433.12 | 61.0 |
| Expenses | N/A | N/A |
| PBT | -269.24 | -82.53 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -269.39 | -82.68 |
About Krebs Biochemicals & Industries Ltd.
| Founded | 1991 |
|---|---|
| Managing Director | Manish Jain |
| NSE Symbol | KREBSBIO |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,27,933.39 | 1,797.35 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,75,833.11 | 6,615.95 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,548.89 | 4,470.00 | 3,132.70 - 3,132.70 |
| Apollo Hospitals Enterprise Ltd. | 1,19,392.31 | 8,435.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,13,154.89 | 1,392.85 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,09,568.82 | 1,093.00 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,06,654.01 | 1,286.40 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,704.91 | 2,268.35 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 96,492.75 | 2,367.75 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 95,090.78 | 1,000.95 | 903.00 - 903.00 |
No Records Found
Latest News
Krebs Biochemicals and Industries inform about newspaper publication
Krebs Biochemicals & Industries informs about certificate
Krebs Biochemicals & Industries informs about trading window closure
Zim Laboratories informs about newspaper advertisements
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zim Laboratories has submitted a copy of newspaper advertisements published in respect of 42nd Annual General Meeting of the Company scheduled to be held on Monday, 29th June, 2026 in the Newspapers, The Financial Express (English) all India Edition, Indian Express (English) Nagpur Edition and Loksatta (Marathi).
The above information is a part of company’s filings submitted to BSE.
Sudarshan Pharma Industries informs about disclosure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Krebs Biochemicals & Industries Ltd. is ₹68.93 as of 2026-06-08.
The market capitalisation of Krebs Biochemicals & Industries Ltd. is ₹139.00 as of 2026-06-05.
The 1-year return of Krebs Biochemicals & Industries Ltd. is 3.92% as of 2026-06-08.
The P/E ratio of Krebs Biochemicals & Industries Ltd. is 0.00 as of 2026-06-08.
The 52-week high and low of Krebs Biochemicals & Industries Ltd. are ₹113.50 and ₹38.33, respectively, as of 2026-06-08.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
